BofA analyst Jordan Lyonnais lowered the firm’s price target on Axon (AXON) to $700 from $805 and keeps a Buy rating on the shares. The firm continues to see Axon’s growth story as intact and sees opportunities for further acceleration, but lowers its price target with current negative sentiment clouding fundamentals.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON:
- SPDR S&P 500 ETF Trust (SPY) Daily Update, 2/25/2026
- Axon: AI-Driven Platform Strength and Long-Term Growth Targets Support Buy Rating
- Early notable gainers among liquid option names on February 25th
- ‘Supercharged with AI’: Taser Maker Axon Stock Surges 22% on 2026 Sales Target
- Axon price target lowered to $735 from $860 at RBC Capital